Report Detail

Service & Software Global Live Cell Imaging Software Market Growth (Status and Outlook) 2022-2028

  • RnM4495259
  • |
  • 11 November, 2022
  • |
  • Global
  • |
  • 103 Pages
  • |
  • LPI(LP Information)
  • |
  • Service & Software

The global market for Live Cell Imaging Software is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Live Cell Imaging Software market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Live Cell Imaging Software market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Live Cell Imaging Software market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Live Cell Imaging Software market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Live Cell Imaging Software players cover Andor Technology, Fluxion Biosciences, Olympus LS, PerkinElmer and Sartorius, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Live Cell Imaging Software market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Live Cell Imaging Software market, with both quantitative and qualitative data, to help readers understand how the Live Cell Imaging Software market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Live Cell Imaging Software market and forecasts the market size by Type (Online and Offline,), by Application (Laboratory, Hospital and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Online
Offline

Segmentation by application
Laboratory
Hospital
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Andor Technology
Fluxion Biosciences
Olympus LS
PerkinElmer
Sartorius
Molecular Devices
Phase Holographic Imaging PHI
Agilent
BioTek
Nanlive
CytoSMART
AutoLCI
MilliporeSigma

Chapter Introduction
Chapter 1: Scope of Live Cell Imaging Software, Research Methodology, etc.
Chapter 2: Executive Summary, global Live Cell Imaging Software market size and CAGR, Live Cell Imaging Software market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Live Cell Imaging Software revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Live Cell Imaging Software revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Live Cell Imaging Software market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Andor Technology, Fluxion Biosciences, Olympus LS, PerkinElmer, Sartorius, Molecular Devices, Phase Holographic Imaging PHI, Agilent and BioTek, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Live Cell Imaging Software Market Size 2017-2028
    • 2.1.2 Live Cell Imaging Software Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Live Cell Imaging Software Segment by Type
    • 2.2.1 Online
    • 2.2.2 Offline
  • 2.3 Live Cell Imaging Software Market Size by Type
    • 2.3.1 Live Cell Imaging Software Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Live Cell Imaging Software Market Size Market Share by Type (2017-2022)
  • 2.4 Live Cell Imaging Software Segment by Application
    • 2.4.1 Laboratory
    • 2.4.2 Hospital
    • 2.4.3 Others
  • 2.5 Live Cell Imaging Software Market Size by Application
    • 2.5.1 Live Cell Imaging Software Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Live Cell Imaging Software Market Size Market Share by Application (2017-2022)

3 Live Cell Imaging Software Market Size by Player

  • 3.1 Live Cell Imaging Software Market Size Market Share by Players
    • 3.1.1 Global Live Cell Imaging Software Revenue by Players (2020-2022)
    • 3.1.2 Global Live Cell Imaging Software Revenue Market Share by Players (2020-2022)
  • 3.2 Global Live Cell Imaging Software Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Live Cell Imaging Software by Regions

  • 4.1 Live Cell Imaging Software Market Size by Regions (2017-2022)
  • 4.2 Americas Live Cell Imaging Software Market Size Growth (2017-2022)
  • 4.3 APAC Live Cell Imaging Software Market Size Growth (2017-2022)
  • 4.4 Europe Live Cell Imaging Software Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Live Cell Imaging Software Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Live Cell Imaging Software Market Size by Country (2017-2022)
  • 5.2 Americas Live Cell Imaging Software Market Size by Type (2017-2022)
  • 5.3 Americas Live Cell Imaging Software Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Live Cell Imaging Software Market Size by Region (2017-2022)
  • 6.2 APAC Live Cell Imaging Software Market Size by Type (2017-2022)
  • 6.3 APAC Live Cell Imaging Software Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Live Cell Imaging Software by Country (2017-2022)
  • 7.2 Europe Live Cell Imaging Software Market Size by Type (2017-2022)
  • 7.3 Europe Live Cell Imaging Software Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Live Cell Imaging Software by Region (2017-2022)
  • 8.2 Middle East & Africa Live Cell Imaging Software Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Live Cell Imaging Software Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Live Cell Imaging Software Market Forecast

  • 10.1 Global Live Cell Imaging Software Forecast by Regions (2023-2028)
    • 10.1.1 Global Live Cell Imaging Software Forecast by Regions (2023-2028)
    • 10.1.2 Americas Live Cell Imaging Software Forecast
    • 10.1.3 APAC Live Cell Imaging Software Forecast
    • 10.1.4 Europe Live Cell Imaging Software Forecast
    • 10.1.5 Middle East & Africa Live Cell Imaging Software Forecast
  • 10.2 Americas Live Cell Imaging Software Forecast by Country (2023-2028)
    • 10.2.1 United States Live Cell Imaging Software Market Forecast
    • 10.2.2 Canada Live Cell Imaging Software Market Forecast
    • 10.2.3 Mexico Live Cell Imaging Software Market Forecast
    • 10.2.4 Brazil Live Cell Imaging Software Market Forecast
  • 10.3 APAC Live Cell Imaging Software Forecast by Region (2023-2028)
    • 10.3.1 China Live Cell Imaging Software Market Forecast
    • 10.3.2 Japan Live Cell Imaging Software Market Forecast
    • 10.3.3 Korea Live Cell Imaging Software Market Forecast
    • 10.3.4 Southeast Asia Live Cell Imaging Software Market Forecast
    • 10.3.5 India Live Cell Imaging Software Market Forecast
    • 10.3.6 Australia Live Cell Imaging Software Market Forecast
  • 10.4 Europe Live Cell Imaging Software Forecast by Country (2023-2028)
    • 10.4.1 Germany Live Cell Imaging Software Market Forecast
    • 10.4.2 France Live Cell Imaging Software Market Forecast
    • 10.4.3 UK Live Cell Imaging Software Market Forecast
    • 10.4.4 Italy Live Cell Imaging Software Market Forecast
    • 10.4.5 Russia Live Cell Imaging Software Market Forecast
  • 10.5 Middle East & Africa Live Cell Imaging Software Forecast by Region (2023-2028)
    • 10.5.1 Egypt Live Cell Imaging Software Market Forecast
    • 10.5.2 South Africa Live Cell Imaging Software Market Forecast
    • 10.5.3 Israel Live Cell Imaging Software Market Forecast
    • 10.5.4 Turkey Live Cell Imaging Software Market Forecast
    • 10.5.5 GCC Countries Live Cell Imaging Software Market Forecast
  • 10.6 Global Live Cell Imaging Software Forecast by Type (2023-2028)
  • 10.7 Global Live Cell Imaging Software Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Andor Technology
    • 11.1.1 Andor Technology Company Information
    • 11.1.2 Andor Technology Live Cell Imaging Software Product Offered
    • 11.1.3 Andor Technology Live Cell Imaging Software Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Andor Technology Main Business Overview
    • 11.1.5 Andor Technology Latest Developments
  • 11.2 Fluxion Biosciences
    • 11.2.1 Fluxion Biosciences Company Information
    • 11.2.2 Fluxion Biosciences Live Cell Imaging Software Product Offered
    • 11.2.3 Fluxion Biosciences Live Cell Imaging Software Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Fluxion Biosciences Main Business Overview
    • 11.2.5 Fluxion Biosciences Latest Developments
  • 11.3 Olympus LS
    • 11.3.1 Olympus LS Company Information
    • 11.3.2 Olympus LS Live Cell Imaging Software Product Offered
    • 11.3.3 Olympus LS Live Cell Imaging Software Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Olympus LS Main Business Overview
    • 11.3.5 Olympus LS Latest Developments
  • 11.4 PerkinElmer
    • 11.4.1 PerkinElmer Company Information
    • 11.4.2 PerkinElmer Live Cell Imaging Software Product Offered
    • 11.4.3 PerkinElmer Live Cell Imaging Software Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 PerkinElmer Main Business Overview
    • 11.4.5 PerkinElmer Latest Developments
  • 11.5 Sartorius
    • 11.5.1 Sartorius Company Information
    • 11.5.2 Sartorius Live Cell Imaging Software Product Offered
    • 11.5.3 Sartorius Live Cell Imaging Software Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Sartorius Main Business Overview
    • 11.5.5 Sartorius Latest Developments
  • 11.6 Molecular Devices
    • 11.6.1 Molecular Devices Company Information
    • 11.6.2 Molecular Devices Live Cell Imaging Software Product Offered
    • 11.6.3 Molecular Devices Live Cell Imaging Software Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Molecular Devices Main Business Overview
    • 11.6.5 Molecular Devices Latest Developments
  • 11.7 Phase Holographic Imaging PHI
    • 11.7.1 Phase Holographic Imaging PHI Company Information
    • 11.7.2 Phase Holographic Imaging PHI Live Cell Imaging Software Product Offered
    • 11.7.3 Phase Holographic Imaging PHI Live Cell Imaging Software Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Phase Holographic Imaging PHI Main Business Overview
    • 11.7.5 Phase Holographic Imaging PHI Latest Developments
  • 11.8 Agilent
    • 11.8.1 Agilent Company Information
    • 11.8.2 Agilent Live Cell Imaging Software Product Offered
    • 11.8.3 Agilent Live Cell Imaging Software Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Agilent Main Business Overview
    • 11.8.5 Agilent Latest Developments
  • 11.9 BioTek
    • 11.9.1 BioTek Company Information
    • 11.9.2 BioTek Live Cell Imaging Software Product Offered
    • 11.9.3 BioTek Live Cell Imaging Software Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 BioTek Main Business Overview
    • 11.9.5 BioTek Latest Developments
  • 11.10 Nanlive
    • 11.10.1 Nanlive Company Information
    • 11.10.2 Nanlive Live Cell Imaging Software Product Offered
    • 11.10.3 Nanlive Live Cell Imaging Software Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Nanlive Main Business Overview
    • 11.10.5 Nanlive Latest Developments
  • 11.11 CytoSMART
    • 11.11.1 CytoSMART Company Information
    • 11.11.2 CytoSMART Live Cell Imaging Software Product Offered
    • 11.11.3 CytoSMART Live Cell Imaging Software Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 CytoSMART Main Business Overview
    • 11.11.5 CytoSMART Latest Developments
  • 11.12 AutoLCI
    • 11.12.1 AutoLCI Company Information
    • 11.12.2 AutoLCI Live Cell Imaging Software Product Offered
    • 11.12.3 AutoLCI Live Cell Imaging Software Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 AutoLCI Main Business Overview
    • 11.12.5 AutoLCI Latest Developments
  • 11.13 MilliporeSigma
    • 11.13.1 MilliporeSigma Company Information
    • 11.13.2 MilliporeSigma Live Cell Imaging Software Product Offered
    • 11.13.3 MilliporeSigma Live Cell Imaging Software Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 MilliporeSigma Main Business Overview
    • 11.13.5 MilliporeSigma Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Live Cell Imaging Software. Industry analysis & Market Report on Live Cell Imaging Software is a syndicated market report, published as Global Live Cell Imaging Software Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Live Cell Imaging Software market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,997.54
5,995.08
3,484.32
6,968.64
498,455.40
996,910.80
298,948.80
597,897.60
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report